product pipeline careers  contact us home about us pipeline partnering news  events investors product pipeline cancer immunology other product pipeline the biolinerx pipeline is generated by systematically identifying validating and inlicensing therapeutic candidates with advantages over current therapies or which address unmet medical needs over  compounds have already been systematically screened and evaluated of which over forty commenced development currently we have one clinicalstage therapeutic candidate and one compound which has commercialized cancer bl  multiple cancer and hematology indications phase  agi  solid tumors nearclinical immunology bl type  diabetes preclinical bl nash preclinical bl liver failure diseases preclinical bl dry eye syndrome preclinical other bl skin lesions commercially launched signup for updates and other news from biolinerx name email copyright �  biolinerx all rights reserved  terms of use  privacy policy web design by xg media    web development  imoon biolinerx ltd  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report biolinerx ltd  product pipeline review   published by global markets direct product code  published july   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license biolinerx ltd  product pipeline review   published july   content info  pages description summary global markets directs biolinerx ltd  product pipeline review   provides an overview of the biolinerx ltds pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of biolinerx ltds complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of biolinerx ltd including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of biolinerx ltds human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the biolinerx ltds pipeline products reasons to buy evaluate biolinerx ltds strategic position with total access to detailed information on its product pipeline assess the growth potential of biolinerx ltd in its therapy areas of focus identify new drug targets and therapeutic classes in the biolinerx ltds rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of biolinerx ltd and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of biolinerx ltd develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of biolinerx ltd and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures biolinerx ltd snapshot biolinerx ltd overview key information key facts biolinerx ltd  research and development overview key therapeutic areas biolinerx ltd  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  combination treatment modalities biolinerx ltd  pipeline products glance biolinerx ltd  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities biolinerx ltd  early stage pipeline products preclinical productscombination treatment modalities biolinerx ltd  drug profiles bl product description mechanism of action rd progress bl product description mechanism of action rd progress ribavirin  hydroxychloroquine product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress cgen product description mechanism of action rd progress biolinerx ltd  pipeline analysis biolinerx ltd  pipeline products by target biolinerx ltd  pipeline products by route of administration biolinerx ltd  pipeline products by molecule type biolinerx ltd  pipeline products by mechanism of action biolinerx ltd  recent pipeline updates biolinerx ltd  dormant projects biolinerx ltd  discontinued pipeline products discontinued pipeline product profiles bl bl bl bl bl bl bl bl bl bl bl bl bl bl bl biolinerx ltd  company statement biolinerx ltd  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables biolinerx ltd key information biolinerx ltd key facts biolinerx ltd  pipeline by indication  biolinerx ltd  pipeline by stage of development  biolinerx ltd  monotherapy products in pipeline  biolinerx ltd  combination treatment modalities in pipeline  biolinerx ltd  phase ii  biolinerx ltd  phase i  biolinerx ltd  preclinical  biolinerx ltd  pipeline by target  biolinerx ltd  pipeline by route of administration  biolinerx ltd  pipeline by molecule type  biolinerx ltd  pipeline products by mechanism of action  biolinerx ltd  recent pipeline updates  biolinerx ltd  dormant developmental projects biolinerx ltd  discontinued pipeline products  biolinerx ltd subsidiaries list of figures biolinerx ltd  pipeline by top  indication  biolinerx ltd  pipeline by stage of development  biolinerx ltd  monotherapy products in pipeline  biolinerx ltd  pipeline by top  target  biolinerx ltd  pipeline by top  route of administration  biolinerx ltd  pipeline by top  molecule type  biolinerx ltd  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved biolinerx  a drug development company careers  contact us home about us pipeline partnering news  events investors about biolinerx biolinerx is a clinicalstage biopharmaceutical company focused on oncology and immunology the company inlicenses novel compounds develops them through preclinical andor clinical stages and then partners with pharmaceutical companies for advanced clinical development andor commercialization company presentation learn more about biolinerx’s unique business model our history and achievements our clinical programs and next in line” advanced preclinical programs click here to open the biolinerx company presentation june  copyright �  biolinerx all rights reserved  terms of use  privacy policy web design by xg media    web development  imoon biolinerx ltd  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports biolinerx ltd  product pipeline review   biolinerx ltd  product pipeline review   wgr  july  global  pages global markets direct description table of content sample report enquiry before buy related reports biolinerx ltd  product pipeline review   summary global markets direct’s ‘biolinerx ltd  product pipeline review  ’ provides an overview of the biolinerx ltd’s pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of biolinerx ltd’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of biolinerx ltd including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of biolinerx ltd’s human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the biolinerx ltd’s pipeline products reasons to buy  evaluate biolinerx ltd’s strategic position with total access to detailed information on its product pipeline  assess the growth potential of biolinerx ltd in its therapy areas of focus  identify new drug targets and therapeutic classes in the biolinerx ltd’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of biolinerx ltd and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of biolinerx ltd  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of biolinerx ltd and identify potential opportunities in those areas  avoid intellectual property rights related issues table of contents table of contents  list of tables  list of figures  biolinerx ltd snapshot  biolinerx ltd overview  key information  key facts  biolinerx ltd  research and development overview  key therapeutic areas  biolinerx ltd  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  combination treatment modalities  biolinerx ltd  pipeline products glance  biolinerx ltd  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  biolinerx ltd  early stage pipeline products  preclinical productscombination treatment modalities  biolinerx ltd  drug profiles  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  ribavirin  hydroxychloroquine  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  cgen  product description  mechanism of action  rd progress  biolinerx ltd  pipeline analysis  biolinerx ltd  pipeline products by target  biolinerx ltd  pipeline products by route of administration  biolinerx ltd  pipeline products by molecule type  biolinerx ltd  pipeline products by mechanism of action  biolinerx ltd  recent pipeline updates  biolinerx ltd  dormant projects  biolinerx ltd  discontinued pipeline products  discontinued pipeline product profiles  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  biolinerx ltd  company statement  biolinerx ltd  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables biolinerx ltd key information  biolinerx ltd key facts  biolinerx ltd  pipeline by indication   biolinerx ltd  pipeline by stage of development   biolinerx ltd  monotherapy products in pipeline   biolinerx ltd  combination treatment modalities in pipeline   biolinerx ltd  phase ii   biolinerx ltd  phase i   biolinerx ltd  preclinical   biolinerx ltd  pipeline by target   biolinerx ltd  pipeline by route of administration   biolinerx ltd  pipeline by molecule type   biolinerx ltd  pipeline products by mechanism of action   biolinerx ltd  recent pipeline updates   biolinerx ltd  dormant developmental projects  biolinerx ltd  discontinued pipeline products   biolinerx ltd subsidiaries  list of figures biolinerx ltd  pipeline by top  indication   biolinerx ltd  pipeline by stage of development   biolinerx ltd  monotherapy products in pipeline   biolinerx ltd  pipeline by top  target   biolinerx ltd  pipeline by top  route of administration   biolinerx ltd  pipeline by top  molecule type   biolinerx ltd  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send biolinerx ltd  product pipeline review   infomarketreportscentercom  us x login sign up facebook twitter linkedin google  mrc blog youtube biolinerx ltd  product pipeline review   home  pharmaceuticals  global markets direct  biolinerx ltd  product pipeline review   report details biolinerx ltd  product pipeline review   sku gmdjul category pharmaceuticals publisher global markets direct pages  published jul skugmdjul categorypharmaceuticals publisherglobal markets direct pages published onjul request discount pay by wireinvoice description table of content list of figures request sample description biolinerx ltd  product pipeline review   summary global markets directs biolinerx ltd  product pipeline review   provides an overview of the biolinerx ltds pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of biolinerx ltds complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of biolinerx ltd including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of biolinerx ltds human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the biolinerx ltds pipeline products reasons to buy  evaluate biolinerx ltds strategic position with total access to detailed information on its product pipeline  assess the growth potential of biolinerx ltd in its therapy areas of focus  identify new drug targets and therapeutic classes in the biolinerx ltds rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of biolinerx ltd and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of biolinerx ltd  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of biolinerx ltd and identify potential opportunities in those areas  avoid intellectual property rights related issues newspress release precision medicine how the life science industry can improve outcomes through to achieve successful precision medicine at scale and to be able to offer it as an everyday treatment option researchers in drug rd need to better understand and manage the reams of unstructured datread more regenerative medicine market to hit  billion by  the current regenerative medicine market is worth  billion globally and will hit over  billion by  as impact of trump administrationread more  benefits of microneedlingmicroneedling hundreds of tiny pin pricks going into your skin might sound weird but it could just be the best thing that ever happened to your faceread more table of content table of contents table of contents  list of tables  list of figures  biolinerx ltd snapshot  biolinerx ltd overview  key information  key facts  biolinerx ltd  research and development overview  key therapeutic areas  biolinerx ltd  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  combination treatment modalities  biolinerx ltd  pipeline products glance  biolinerx ltd  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  biolinerx ltd  early stage pipeline products  preclinical productscombination treatment modalities  biolinerx ltd  drug profiles  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  ribavirin  hydroxychloroquine  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  cgen  product description  mechanism of action  rd progress  biolinerx ltd  pipeline analysis  biolinerx ltd  pipeline products by target  biolinerx ltd  pipeline products by route of administration  biolinerx ltd  pipeline products by molecule type  biolinerx ltd  pipeline products by mechanism of action  biolinerx ltd  recent pipeline updates  biolinerx ltd  dormant projects  biolinerx ltd  discontinued pipeline products  discontinued pipeline product profiles  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  biolinerx ltd  company statement  biolinerx ltd  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of figures list of tables biolinerx ltd key information  biolinerx ltd key facts  biolinerx ltd  pipeline by indication   biolinerx ltd  pipeline by stage of development   biolinerx ltd  monotherapy products in pipeline   biolinerx ltd  combination treatment modalities in pipeline   biolinerx ltd  phase ii   biolinerx ltd  phase i   biolinerx ltd  preclinical   biolinerx ltd  pipeline by target   biolinerx ltd  pipeline by route of administration   biolinerx ltd  pipeline by molecule type   biolinerx ltd  pipeline products by mechanism of action   biolinerx ltd  recent pipeline updates   biolinerx ltd  dormant developmental projects  biolinerx ltd  discontinued pipeline products   biolinerx ltd subsidiaries  list of figures biolinerx ltd  pipeline by top  indication   biolinerx ltd  pipeline by stage of development   biolinerx ltd  monotherapy products in pipeline   biolinerx ltd  pipeline by top  target   biolinerx ltd  pipeline by top  route of administration   biolinerx ltd  pipeline by top  molecule type   biolinerx ltd  pipeline products by top  mechanism of action   please select license type single user electronic pdf   site user electronic pdf   enterprise wide electronic pdf   add to cart buy now related reports global corn dry milling products market professional survey report  global diabetic food products sales market report  global wound care product industry report  global electrosurgical products market professional survey report  lighting product markets in the top  american countries to  request sample mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send request discount mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send pay by wireinvoice mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  single user electronic pdf site user electronic pdf enterprise wide electronic pdf cd rom hard copy send request quote mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send market reports center  copyright  all rights reserved biolinerx ltd  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports biolinerx ltd  product pipeline review   biolinerx ltd  product pipeline review   wgr  may  global  pages global markets direct description table of content sample report enquiry before buy related reports biolinerx ltd  product pipeline review  summaryglobal markets direct’s ‘biolinerx ltd  product pipeline review  ’ provides an overview of the biolinerx ltd’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of biolinerx ltd’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of biolinerx ltd including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of biolinerx ltd’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the biolinerx ltd’s pipeline productsreasons to buy evaluate biolinerx ltd’s strategic position with total access to detailed information on its product pipeline assess the growth potential of biolinerx ltd in its therapy areas of focus identify new drug targets and therapeutic classes in the biolinerx ltd’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of biolinerx ltd and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of biolinerx ltd develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of biolinerx ltd and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures biolinerx ltd snapshot biolinerx ltd overview key information key facts biolinerx ltd  research and development overview key therapeutic areas biolinerx ltd  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  combination treatment modalities biolinerx ltd  pipeline products glance biolinerx ltd  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities biolinerx ltd  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities biolinerx ltd  drug profiles bl product description mechanism of action rd progress bl product description mechanism of action rd progress ribavirin  hydroxychloroquine product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress cgena product description mechanism of action rd progress cgenb product description mechanism of action rd progress cgen product description mechanism of action rd progress edp product description mechanism of action rd progress edp product description mechanism of action rd progress edp product description mechanism of action rd progress biolinerx ltd  pipeline analysis biolinerx ltd  pipeline products by target biolinerx ltd  pipeline products by route of administration biolinerx ltd  pipeline products by molecule type biolinerx ltd  pipeline products by mechanism of action biolinerx ltd  recent pipeline updates biolinerx ltd  dormant projects biolinerx ltd  discontinued pipeline products discontinued pipeline product profiles bl bl bl bl bl bl bl bl bl bl bl bl bl bl bl biolinerx ltd  company statement biolinerx ltd  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesbiolinerx ltd key information biolinerx ltd key facts biolinerx ltd  pipeline by indication  biolinerx ltd  pipeline by stage of development  biolinerx ltd  monotherapy products in pipeline  biolinerx ltd  combination treatment modalities in pipeline  biolinerx ltd  phase ii  biolinerx ltd  phase i  biolinerx ltd  preclinical  biolinerx ltd  discovery  biolinerx ltd  pipeline by target  biolinerx ltd  pipeline by route of administration  biolinerx ltd  pipeline by molecule type  biolinerx ltd  pipeline products by mechanism of action  biolinerx ltd  recent pipeline updates  biolinerx ltd  dormant developmental projects biolinerx ltd  discontinued pipeline products  biolinerx ltd subsidiaries list of figuresbiolinerx ltd  pipeline by top  indication  biolinerx ltd  pipeline by stage of development  biolinerx ltd  monotherapy products in pipeline  biolinerx ltd  pipeline by top  target  biolinerx ltd  pipeline by top  route of administration  biolinerx ltd  pipeline by top  molecule type  biolinerx ltd  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send market report biolinerx ltd  product pipeline review   about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing biolinerx ltd  product pipeline review   jul    global markets direct   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents companies request details related global markets directs biolinerx ltd  product pipeline review   provides an overview of the biolinerx ltds pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of biolinerx ltds complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of biolinerx ltd including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of biolinerx ltds human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the biolinerx ltds pipeline productsreasons to buyevaluate biolinerx ltds strategic position with total access to detailed information on its product pipelineassess the growth potential of biolinerx ltd in its therapy areas of focusidentify new drug targets and therapeutic classes in the biolinerx ltds rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of biolinerx ltd and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of biolinerx ltddevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of biolinerx ltd and identify potential opportunities in those areasavoid intellectual property rights related issues table of contentstable of contentslist of tableslist of figuresbiolinerx ltd snapshotbiolinerx ltd overviewkey informationkey factsbiolinerx ltd  research and development overviewkey therapeutic areasbiolinerx ltd  pipeline reviewpipeline products by stage of developmentpipeline products  monotherapypipeline products  combination treatment modalitiesbiolinerx ltd  pipeline products glancebiolinerx ltd  clinical stage pipeline productsphase ii productscombination treatment modalitiesphase i productscombination treatment modalitiesbiolinerx ltd  early stage pipeline productspreclinical productscombination treatment modalitiesbiolinerx ltd  drug profilesblproduct descriptionmechanism of actionrd progressblproduct descriptionmechanism of actionrd progressribavirin  hydroxychloroquineproduct descriptionmechanism of actionrd progressblproduct descriptionmechanism of actionrd progressblproduct descriptionmechanism of actionrd progressblproduct descriptionmechanism of actionrd progressblproduct descriptionmechanism of actionrd progressblproduct descriptionmechanism of actionrd progressblproduct descriptionmechanism of actionrd progresscgenproduct descriptionmechanism of actionrd progressbiolinerx ltd  pipeline analysisbiolinerx ltd  pipeline products by targetbiolinerx ltd  pipeline products by route of administrationbiolinerx ltd  pipeline products by molecule typebiolinerx ltd  pipeline products by mechanism of actionbiolinerx ltd  recent pipeline updatesbiolinerx ltd  dormant projectsbiolinerx ltd  discontinued pipeline productsdiscontinued pipeline product profilesblblblblblblblblblblblblblblblbiolinerx ltd  company statementbiolinerx ltd  locations and subsidiarieshead officeother locations  subsidiariesappendixmethodologycoveragesecondary researchprimary researchexpert panel validationcontact usdisclaimerlist of tablesbiolinerx ltd key informationbiolinerx ltd key factsbiolinerx ltd  pipeline by indication biolinerx ltd  pipeline by stage of development biolinerx ltd  monotherapy products in pipeline biolinerx ltd  combination treatment modalities in pipeline biolinerx ltd  phase ii biolinerx ltd  phase i biolinerx ltd  preclinical biolinerx ltd  pipeline by target biolinerx ltd  pipeline by route of administration biolinerx ltd  pipeline by molecule type biolinerx ltd  pipeline products by mechanism of action biolinerx ltd  recent pipeline updates biolinerx ltd  dormant developmental projectsbiolinerx ltd  discontinued pipeline products biolinerx ltd subsidiarieslist of figuresbiolinerx ltd  pipeline by top  indication biolinerx ltd  pipeline by stage of development biolinerx ltd  monotherapy products in pipeline biolinerx ltd  pipeline by top  target biolinerx ltd  pipeline by top  route of administration biolinerx ltd  pipeline by top  molecule type biolinerx ltd  pipeline products by top  mechanism of action  companies mentioned in this reportbiolinerx ltd this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher global markets direct is a leading provider of global business intelligence and market analysis it publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industryspecific information publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc biolinerx ltd  product pipeline review   trends statistics segment and forecasts market size share analysis  market research store     gmt office hours  uscan toll free  us office no home categories become publisher news about us contact us select category consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media semiconductor chemical and materials metallurgical market research search home  life sciences  pharmaceuticals biolinerx ltd  product pipeline review   published jul  format pdf  global markets direct  number of pages   code mrs   report details table of content inquiry for buying request sample biolinerx ltd  product pipeline review   summary global markets direct’s ‘biolinerx ltd  product pipeline review  ’ provides an overview of the biolinerx ltd’s pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of biolinerx ltd’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of biolinerx ltd including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of biolinerx ltd’s human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the biolinerx ltd’s pipeline products reasons to buy  evaluate biolinerx ltd’s strategic position with total access to detailed information on its product pipeline  assess the growth potential of biolinerx ltd in its therapy areas of focus  identify new drug targets and therapeutic classes in the biolinerx ltd’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of biolinerx ltd and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of biolinerx ltd  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of biolinerx ltd and identify potential opportunities in those areas  avoid intellectual property rights related issues table of contents table of contents  list of tables  list of figures  biolinerx ltd snapshot  biolinerx ltd overview  key information  key facts  biolinerx ltd  research and development overview  key therapeutic areas  biolinerx ltd  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  combination treatment modalities  biolinerx ltd  pipeline products glance  biolinerx ltd  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  biolinerx ltd  early stage pipeline products  preclinical productscombination treatment modalities  biolinerx ltd  drug profiles  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  ribavirin  hydroxychloroquine  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  bl  product description  mechanism of action  rd progress  cgen  product description  mechanism of action  rd progress  biolinerx ltd  pipeline analysis  biolinerx ltd  pipeline products by target  biolinerx ltd  pipeline products by route of administration  biolinerx ltd  pipeline products by molecule type  biolinerx ltd  pipeline products by mechanism of action  biolinerx ltd  recent pipeline updates  biolinerx ltd  dormant projects  biolinerx ltd  discontinued pipeline products  discontinued pipeline product profiles  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  bl  biolinerx ltd  company statement  biolinerx ltd  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables biolinerx ltd key information  biolinerx ltd key facts  biolinerx ltd  pipeline by indication   biolinerx ltd  pipeline by stage of development   biolinerx ltd  monotherapy products in pipeline   biolinerx ltd  combination treatment modalities in pipeline   biolinerx ltd  phase ii   biolinerx ltd  phase i   biolinerx ltd  preclinical   biolinerx ltd  pipeline by target   biolinerx ltd  pipeline by route of administration   biolinerx ltd  pipeline by molecule type   biolinerx ltd  pipeline products by mechanism of action   biolinerx ltd  recent pipeline updates   biolinerx ltd  dormant developmental projects  biolinerx ltd  discontinued pipeline products   biolinerx ltd subsidiaries  list of figures biolinerx ltd  pipeline by top  indication   biolinerx ltd  pipeline by stage of development   biolinerx ltd  monotherapy products in pipeline   biolinerx ltd  pipeline by top  target   biolinerx ltd  pipeline by top  route of administration   biolinerx ltd  pipeline by top  molecule type   biolinerx ltd  pipeline products by top  mechanism of action   inquiry for buying please fill your details below to inquire about this report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit request sample please fill your details below to receive sample report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit related reports global guaifenesin api market research   jun  heyreport  pages    code  mrs   summary guaifenesin is used to relieve chest congestion guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery guaifenesin is in a class of medications called expectorants it works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways the global guaifenesin api market is estimated to reach xxx million usd in  in the report heyreport says pharmaceuticals dominates the largest application sha read more global nerve gas autoinjector market research report forecast  to  apr  sp consulting  pages    code  mrs   the global nerve gas autoinjector market research report forecast  is a valuable source of insightful data for business strategists it provides the nerve gas autoinjector industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this nerve gas autoinjector market study provides comprehensive data which enhances t read more global parkinsons disease drug market research report forecast  to  apr  sp consulting  pages    code  mrs   the global parkinsons disease drug market research report forecast  is a valuable source of insightful data for business strategists it provides the parkinsons disease drug industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this parkinsons disease drug market study provides comprehensive data which enhance read more global minimally invasive surgery video columns market research report forecast  to  apr  sp consulting  pages    code  mrs   the global minimally invasive surgery video columns market research report forecast  is a valuable source of insightful data for business strategists it provides the minimally invasive surgery video columns industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this minimally invasive surgery video columns market read more global botanical and plantderived drugs market research report forecast  to  apr  sp consulting  pages    code  mrs   the global botanical and plantderived drugs market research report forecast  is a valuable source of insightful data for business strategists it provides the botanical and plantderived drugs industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this botanical and plantderived drugs market study provides compr read more global telehealth monitoring market research report forecast  to  apr  sp consulting  pages    code  mrs   the global telehealth monitoring market research report forecast  is a valuable source of insightful data for business strategists it provides the telehealth monitoring industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this telehealth monitoring market study provides comprehensive data which enhances the read more global pipeline drugs for hematopoietic stem cell transplantation market research report forecast  to  apr  sp consulting  pages    code  mrs   the global pipeline drugs for hematopoietic stem cell transplantation market research report forecast  is a valuable source of insightful data for business strategists it provides the pipeline drugs for hematopoietic stem cell transplantation industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this pipeline dr read more chlamydia infections global clinical trials review h  may  globaldata  pages    code  mrs   chlamydia infections global clinical trials review h  summary globaldatas clinical trial report “chlamydia infections global clinical trials review h  provides an overview of chlamydia infections clinical trials scenario this report provides top line data relating to the clinical trials on chlamydia infections report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe the report offers coverage of disease clini read more childhood epilepsy global clinical trials review h  may  globaldata  pages    code  mrs   childhood epilepsy global clinical trials review h  summary globaldatas clinical trial report “childhood epilepsy global clinical trials review h  provides an overview of childhood epilepsy clinical trials scenario this report provides top line data relating to the clinical trials on childhood epilepsy report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe the report offers coverage of disease clinical tria read more chikungunya fever global clinical trials review h  may  globaldata  pages    code  mrs   chikungunya fever global clinical trials review h  summary globaldatas clinical trial report “chikungunya fever global clinical trials review h  provides an overview of chikungunya fever clinical trials scenario this report provides top line data relating to the clinical trials on chikungunya fever report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe the report offers coverage of disease clinical trials b read more payment mode single user  usd multi user  usd corporate user  usd latest report  global nonslip epoxy glass flake paint market research report  global parking sensors market research report  global nitrogen oxide sensor market research report  global nuclear density gauge market research report  global automotive interior materials market research report view more latest news global chitosan market set for rapid growth to reach usd  billion by  zion market research has published a new report titled chitosan market for water treatment biomed development of ecommerce to reshape global mobile hotspot router market mobile hotspot is a popular feature on smart phones that provide wireless internet access on many global carotenoids market is expected to reach around usd  billion in  zion market research has published a new report titled carotenoids market by type astaxanthin be soaring demand from food  beverages industry to act as prime driving for ascorbic acid market reports zion market research ascorbic acid is extensively available in nature mostly rich in leafy vegetables and fresh fruits global energy management system ems market is set for a rapid growth and is expected to reach usd  million by  zion market research has published a new report titled energy management system market ems by so view more single user  usd view pricing find help how to order disclaimer faqs return policy sitemap our company about us terms and conditions privacy policy we accept the following payment methods     market research store  market research reports biolinerx ltd  product pipeline review    reportsnreports market research report welcome guest    registerlogin   contact us   about us      advanced search home ›  pharmaceuticals ›  report detail biolinerx ltd  product pipeline review   published may  no of pages  price  single user license us   corporate user license us     report description table of contents inquire before buying global markets directs biolinerx ltd product pipeline review  provides an overview of the biolinerx ltds pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of biolinerx ltds complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of biolinerx ltd including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of biolinerx ltds human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the biolinerx ltds pipeline productsreasons to buyevaluate biolinerx ltds strategic position with total access to detailed information on its product pipelineassess the growth potential of biolinerx ltd in its therapy areas of focusidentify new drug targets and therapeutic classes in the biolinerx ltds rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of biolinerx ltd and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of biolinerx ltddevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of biolinerx ltd and identify potential opportunities in those areasavoid intellectual property rights related issues biolinerx ltd  product pipeline review   table of contentstable of contents list of tables list of figures biolinerx ltd snapshot biolinerx ltd overview key information key facts biolinerx ltd  research and development overview key therapeutic areas biolinerx ltd  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  combination treatment modalities biolinerx ltd  pipeline products glance biolinerx ltd  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities biolinerx ltd  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities biolinerx ltd  drug profiles bl product description mechanism of action rd progress bl product description mechanism of action rd progress ribavirin  hydroxychloroquine product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress cgena product description mechanism of action rd progress cgenb product description mechanism of action rd progress cgen product description mechanism of action rd progress edp product description mechanism of action rd progress edp product description mechanism of action rd progress edp product description mechanism of action rd progress biolinerx ltd  pipeline analysis biolinerx ltd  pipeline products by target biolinerx ltd  pipeline products by route of administration biolinerx ltd  pipeline products by molecule type biolinerx ltd  pipeline products by mechanism of action biolinerx ltd  recent pipeline updates biolinerx ltd  dormant projects biolinerx ltd  discontinued pipeline products discontinued pipeline product profiles bl bl bl bl bl bl bl bl bl bl bl bl bl bl bl biolinerx ltd  company statement biolinerx ltd  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesbiolinerx ltd key information biolinerx ltd key facts biolinerx ltd  pipeline by indication  biolinerx ltd  pipeline by stage of development  biolinerx ltd  monotherapy products in pipeline  biolinerx ltd  combination treatment modalities in pipeline  biolinerx ltd  phase ii  biolinerx ltd  phase i  biolinerx ltd  preclinical  biolinerx ltd  discovery  biolinerx ltd  pipeline by target  biolinerx ltd  pipeline by route of administration  biolinerx ltd  pipeline by molecule type  biolinerx ltd  pipeline products by mechanism of action  biolinerx ltd  recent pipeline updates  biolinerx ltd  dormant developmental projects biolinerx ltd  discontinued pipeline products  biolinerx ltd subsidiaries list of figuresbiolinerx ltd  pipeline by top  indication  biolinerx ltd  pipeline by stage of development  biolinerx ltd  monotherapy products in pipeline  biolinerx ltd  pipeline by top  target  biolinerx ltd  pipeline by top  route of administration  biolinerx ltd  pipeline by top  molecule type  biolinerx ltd  pipeline products by top  mechanism of action   published by global markets direct product code global markets direct did you find what you arewere looking for  if not read below and browse through other relevant pages for similar market research reports or get in touch with us through the formcontact info in your right navigation panel and well share relevant market report titles for you to explore related reports global protein powder detailed analysis report  this report mainly introduces volume and value market share by players by regions by product type by consumers and also their price change details as a detailed analysis report it covers all details inside analysis and opinion in protein powder  global and united states bacillus subtilis depth research report  this report mainly introduces volume and value market share by players by regions by product type by consumers and also their price change details as a depth research report it covers all details inside analysis and opinion in bacillus subtilis  global varicose vein treatment market professional survey report  this report studies varicose vein treatment in global market especially in north america china europe southeast asia japan and india with production revenue consumption import and export in these regions from  to  and forecast to  global corifollitropin alfa market professional survey report  this report studies corifollitropin alfa in global market especially in north america china europe southeast asia japan and india with production revenue consumption import and export in these regions from  to  and forecast to  asiapacific recombinant coagulation factors market report  in this report the asiapacific recombinant coagulation factors market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report spl asiapacific opioids market report  in this report the asiapacific opioids market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report split asiapacific into sev asiapacific narcolepsy drugs market report  in this report the asiapacific narcolepsy drugs market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report split asiapacific asiapacific morphine market report  in this report the asiapacific morphine market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report split asiapacific into se asiapacific meperidine demerol market report  in this report the asiapacific meperidinedemerol market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report split asiapaci asiapacific hemodialysis powder solution market report  in this report the asiapacific hemodialysis powder solution market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report split  why reportsnreportscom  market research reports and growing top fortune  organizations trust us for research data  support on call as well as emails your details are safe with us free support for your research requirements report delivery email delivery time upto  hrs  working days upto  hrs max  weekends and public holidays research support  custom research if this business study does not have the data and information analysis you need contact us with your research requirements we explore available market research reports to map your needs and share report titles with you alternatively we can also offer custom research that suits your budget and timelines share your information requirements here connect with us email salesreportsandreportscom call       home category publisher country latest reports markets discounted reports upcoming reports contact us subscription option using our subscription option you get access to market research reports and industry data of consumer goods market as per your needs get the best of consumer goods research reports by utilizing your research budgets in an optimum way more about our subscription option report alerts get email alerts about market research reports from industries and publishers of your interest please enter a valid email id thank you you have successfully subscribed to our report alerts avail upto  discount on below publisher reports technavio azoth analytics   reportsnreports all rights reserved disclamer privacy policy  terms and conditions  our market research blog  sitemap feeds rss  latest reports biolinerx ltd  product pipeline review   trends share size research report uscanada toll free home global markets direct pharmaceutical biolinerx ltd  product pipeline review   biolinerx ltd  product pipeline review   published by  global markets direct published date  jul  category  pharmaceutical no of pages   pages description table of content check discount biolinerx ltd  product pipeline review  summaryglobal markets directs biolinerx ltd  product pipeline review   provides an overview of the biolinerx ltds pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of biolinerx ltds complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of biolinerx ltd including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of biolinerx ltds human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the biolinerx ltds pipeline productsreasons to buy evaluate biolinerx ltds strategic position with total access to detailed information on its product pipeline assess the growth potential of biolinerx ltd in its therapy areas of focus identify new drug targets and therapeutic classes in the biolinerx ltds rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of biolinerx ltd and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of biolinerx ltd develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of biolinerx ltd and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures biolinerx ltd snapshot biolinerx ltd overview key information key facts biolinerx ltd  research and development overview key therapeutic areas biolinerx ltd  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  combination treatment modalities biolinerx ltd  pipeline products glance biolinerx ltd  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities biolinerx ltd  early stage pipeline products preclinical productscombination treatment modalities biolinerx ltd  drug profiles bl product description mechanism of action rd progress bl product description mechanism of action rd progress ribavirin  hydroxychloroquine product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress bl product description mechanism of action rd progress cgen product description mechanism of action rd progress biolinerx ltd  pipeline analysis biolinerx ltd  pipeline products by target biolinerx ltd  pipeline products by route of administration biolinerx ltd  pipeline products by molecule type biolinerx ltd  pipeline products by mechanism of action biolinerx ltd  recent pipeline updates biolinerx ltd  dormant projects biolinerx ltd  discontinued pipeline products discontinued pipeline product profiles bl bl bl bl bl bl bl bl bl bl bl bl bl bl bl biolinerx ltd  company statement biolinerx ltd  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesbiolinerx ltd key information biolinerx ltd key facts biolinerx ltd  pipeline by indication  biolinerx ltd  pipeline by stage of development  biolinerx ltd  monotherapy products in pipeline  biolinerx ltd  combination treatment modalities in pipeline  biolinerx ltd  phase ii  biolinerx ltd  phase i  biolinerx ltd  preclinical  biolinerx ltd  pipeline by target  biolinerx ltd  pipeline by route of administration  biolinerx ltd  pipeline by molecule type  biolinerx ltd  pipeline products by mechanism of action  biolinerx ltd  recent pipeline updates  biolinerx ltd  dormant developmental projects biolinerx ltd  discontinued pipeline products  biolinerx ltd subsidiaries list of figuresbiolinerx ltd  pipeline by top  indication  biolinerx ltd  pipeline by stage of development  biolinerx ltd  monotherapy products in pipeline  biolinerx ltd  pipeline by top  target  biolinerx ltd  pipeline by top  route of administration  biolinerx ltd  pipeline by top  molecule type  biolinerx ltd  pipeline products by top  mechanism of action   make an enquiry before buying this report please fill the enquiry form below full name  your email  job title  company  phone no  pls affix country code message security code   choose license type  select user license single license user  multiple license user  do you wish to check sample of this report order a sample report have query on this report related news tetraphases antibiotic eravacycline succeeds stage clinical trial sperm count in men across developed countries declining sharply study greenland darkens with fear of rising sea level intensifying microsoft paint moving towards retirement declares microsoft grab gets us bn funding from didi and softbank research assistance we will be happy to help you find what you need please call us or write to us  uscanada toll free tel   email  salesresearchmozus microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft biolinerx ltd blrx  stock predictions  price targets facebook autocomplete demo post a rating  month price target   home trending sign up log in biolinerx ltd blrx median target price   upside positive ratings  of  analysts latest  maxim group  buy     view all analyst ratings for blrx » flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry flashratings  privacy facebook autocomplete demo post a rating  month price target   trending sign up log in privacy flashratings takes the privacy of its users seriously we are committed to safeguarding the privacy of our users while providing a personalised and valuable service this privacy policy statement explains the data processing practices of flashratingscom if you have any requests concerning your personal information or any queries with regard to these practices please contact us here  flashratings collects personal information when you register or when you provide such information voluntarily  we use cookies and other technologies to find out how you use flashratings  flashratings accesses information automatically when you visit our site this information includes url ipaddress browsertype language as well as date and time of your visit  we dont pass on personal information to any third party beyond other flashratings users as specified above without your explicit approval  only summarized depersonalized information is provided to third parties  personal information is used for providing services requested by the user including services with personalized content  additionally we use your personal information for internal research in order to improve your online experience as well as our technologies and services terms of use by using this website you agree to the following terms of use the content on this site including news quotes data and other information is provided by flashratings inc and its third party content providers for your personal information only and is not intended for trading purposes content on this site is not appropriate for the purposes of making a decision to carry out a transaction or trade nor does it provide any form of advice investment tax legal amounting to investment advice or make any recommendations regarding particular financial instruments investments or products neither flashratings inc nor its third party content providers shall be liable for any errors inaccuracies or delays in content or for any actions taken in reliance thereon flashratings inc expressly disclaims all warranties expressed or implied as to the accuracy of any the content provided or as to the fitness of the information for any purpose although flashratings inc makes reasonable efforts to obtain reliable content from third parties flashratings inc does not guarantee the accuracy of or endorse the views or opinions given by any third party content provider this site may point to other internet sites that may be of interest to you however flashratings inc does not endorse or take responsibility for the content on such other sites flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising biolinerx  a drug development company careers  contact us home about us pipeline partnering news  events investors about biolinerx biolinerx is a clinicalstage biopharmaceutical company focused on oncology and immunology the company inlicenses novel compounds develops them through preclinical andor clinical stages and then partners with pharmaceutical companies for advanced clinical development andor commercialization company presentation learn more about biolinerx’s unique business model our history and achievements our clinical programs and next in line” advanced preclinical programs click here to open the biolinerx company presentation june  copyright �  biolinerx all rights reserved  terms of use  privacy policy web design by xg media    web development  imoon biolinerx  wikipedia biolinerx from wikipedia the free encyclopedia jump to navigation search biolinerx ltd type public traded as nasdaq blrx tase blrx industry biotechnology founded   headquarters modiin israel key people philip serlin ceo services drug development owners novartis   website wwwbiolinerxcom footnotes  references  biolinerx office in har hotzvim technology park jerusalem biolinerx hebrew ביוליין אר אקס‎‎ or bioline is a publicly traded drug development company that seeks to discover compounds for disease treatment and develop them into commercializable drugs headquartered in israel its shares are traded on the nasdaq capital market and on the tel aviv stock exchange contents  operations  pipeline  business model  corporate history  management  see also  references  external links operationsedit biolinerx is a drug development company that seeks to discover compounds with potential to treat a variety of diseases including cancer schizophrenia and cardiac deterioration when promising compounds are discovered bioline leads them through preclinical trials and engages other companies to advance the compounds development into commercializable drugs the company entered into its first major commercialization agreement in  when it partnered with ikaria holdings inc to develop its bl compound in  bioline entered into a commercialization agreement with cypress bioscience inc for development of its bl compound the agreement with cypress was canceled in  when the company was taken over by ramius llc pipelineedit below is a partial list of drug compounds in various stages of development by biolinerx unless indicated otherwise they have not obtained regulatory approval in relation to the diseases cited bl – orally available neuropathic pain bl – orally available gabaenhanced antipsychotic for treatment of schizophrenia bl – orally available small molecule for treatment of neuropathic pain bl – liquid polymer injected into patients suffering from acute myocardial infarction invented by smadar cohen of bengurion university bl  a potent and selective cannabinoid receptor type  cbr agonist intended as a novel treatment for dry eye syndrome des  bl – cream treatment for seborrheic keratosis skin lesions bl – orally available antiinflammatory drug invented by hermona soreq of the hebrew university of jerusalem bl – orally administered treatment for hepatitis c developed by professor philippe halfon cofounder and president of genoscience bl – secondgeneration ns protease inhibitor for oral treatment of hepatitis c invented by philippe halfon business modeledit see also bench to bedside and proof of concept biolines business model consists of three stages in the first stage called the bench stage the potential drug candidate is evaluated from both scientific and marketing perspectives in the second stage called the bedside stage bioline accompanies the drug through early clinical trials in the third stage the partner stage bioline enters into strategic partnership with a pharmaceutical company to see the drug through its advanced clinical trials and bring it to the market corporate historyedit biolinerx was established in  as a joint venture of teva hadasit bioholdings the jerusalem development authority yehuda zisapel and other investors it executed an initial public offering on the tel aviv stock exchange in february  raising  million nis  million – the tases largest biotech ipo until that time in august  biolines adrs began trading on the nasdaq capital market in january  biolinerx announced a deal with genoscience a french pharmaceutical company to jointly develop and market the bl compound as a treatment for hepatitis c at the end of  novartis acquired a  stake in the company as a strategic move to gain access to israelisourced drug candidates managementedit morris laster downstate medical center md and suny albany bsc alumnus was ceo of biolinerx until  he was replaced by kinneret savitsky alumnus of tel aviv university masters and phd and the hebrew university of jerusalem bsc early in  savitsky was replaced as ceo by bioline coo philip serlin on october   see alsoedit translational medicine ta bluetech index list of israeli companies quoted on the nasdaq referencesedit  blrx profile biolinerx ltd stock yahoo finance  retrieved  november    a b novartis makes m investment in biolinerx industry watch genetic engineering  biotechnology news    december  p    brinn david  june  biolinerx—israels biotech supermarket israelc archived from the original on  april  retrieved  november    habibvaldhorn shiri  april  biolinerx earns m milestone payment globes retrieved  november  permanent dead link  weinreb gali  may  biolinerx and cypress cancel schizophrenia drug agreement globes archived from the original on  june  retrieved  november    biolinerx inlicenses novel compound for treatment of neuropathic pain archived from the original on    israeli co to hold clinical trial for treatment of schizophrenia in india the hindu business line jerusalem  november  retrieved  november    biolinerx  september  biolinerx announces positive preliminary results from phase i clinical trial of bl for neuropathic pain press release jerusalem retrieved  november  – via business wire   bioline looks to heart attack treatment clinical trial globes  february  retrieved  november  permanent dead link  us company buys exclusive license for israeli heart attack drug for  million israelc  july  retrieved  november    httpwwwbiolinerxcomdefaultasppageiditemid  wrobel sharon  september  bioline rx gets european device confirmation for bl drug bloomberg retrieved  november    biolinerx has acquired the rights to compound bl from yissum and prof soreq the hebrew university of jerusalem the edmond and lily safra center for brain sciences  june  retrieved  november    biolinerx signs pact with genoscience  rfs pharma to develop and commercialize bl to treat hepatitis c pharmabizcom jerusalem israel  february  archived from the original on  february  retrieved  february    biolinerx—overview biolinerx  archived from the original on  september  retrieved  november  selfpublished source  grayeff yigal  january  biolinerx signs  deals to develop drugs jerusalem post archived from the original on  february  retrieved  november  – via ivc research center   cohen omri  february  biotech comes of age bioline floats at halfbillion shekel market cap themarker retrieved  november  bioline therapeutics today pulled off its initial public offering in tel aviv raising nis  million at a company valuation of nis  million making this the biggest flotation by a biotechnology company in local history   rheinheimer laura  february  biolinerx raises m in tases largest biomedical ipo jerusalem post retrieved  november  biolinerx ltd on wednesday priced the largest ever initial public offering of a biomedical company on the tel aviv stock exchange raising a total of nis  million or m   biolinerx adrs begin trading on nasdaq  august  retrieved  november  – via highbeam research citation not found  cohen tova  july  magnowski daniel ed biolinerx adrs to begin trading on nasdaq monday reuters   wang lu  january  achillion biolinerx jj snack rubicon us equity movers bloomberg news archived from the original on  january    kinneret livnat savitsky phd executive profile  biography bloomberg business retrieved  february    httpswwwbloombergcomresearchstockspeoplepersonasppersonidprivcapid external linksedit biojerusalem jerusalem development authority office of the chief scientist of israel v t e israeli companies traded on nasdaq healthcare alcobra biolinerx biondvax pharmaceutical compugen enzymotec given imaging kamada mazor robotics medigus oramed pharmaceuticals perrigo company pluristem therapeutics rewalk robotics rosetta genomics syneron medical communication  networks allot communications alvarion audiocodes b communications ceragon networks dsp group ezchip semiconductor gilat satellite networks internet gold golden lines orckit communications partner communications company radcom radvision rit technologies rr media software attunity bluephoenix solutions bos better online solutions check point software technologies clicksoftware technologies commtouch software cimatron cyberark formula systems  jacada magic software enterprises mind cti nice systems perion network radware sapiens international corporation nv verint systems wix electronics camtek ceva eltek kornit digital mellanox technologies nova measuring instruments orbotech solaredge tower semiconductor security  defense arotech elbit systems ituran location and control magal security systems pointer telocation rada electronic industries tat technologies consumer goods caesarstone sdotyam sodastream international conglomerates ampalamerican israel corporation elbit imaging isramco this company is americanbased but is traded on the tase as a result of a merger with israeli drug maker agis retrieved from httpsenwikipediaorgwindexphptitlebiolinerxoldid categories companies listed on tasebiotechnology companies established in biotechnology companies of israelbiotechnology companiescompanies listed on nasdaqdrug discovery companies establishments in israelhidden categories all articles with dead external linksarticles with dead external links from july articles with permanently dead external linksaccuracy disputes from february all articles with broken links to citationspages using deprecated image syntaxarticles containing hebrewlanguage text navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages עברית edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view creative commons — attributionsharealike  unported — cc bysa  skip to content menu help us build a vibrant collaborative global commons donate now creative commons creative commons license deed attributionsharealike  unported cc bysa  this is a humanreadable summary of and not a substitute for the license disclaimer you are free to share — copy and redistribute the material in any medium or format adapt — remix transform and build upon the material for any purpose even commercially the licensor cannot revoke these freedoms as long as you follow the license terms under the following terms attribution — you must give appropriate credit provide a link to the license and indicate if changes were made you may do so in any reasonable manner but not in any way that suggests the licensor endorses you or your use attribute this work sharealike — if you remix transform or build upon the material you must distribute your contributions under the same license as the original no additional restrictions — you may not apply legal terms or technological measures that legally restrict others from doing anything the license permits notices you do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation no warranties are given the license may not give you all of the permissions necessary for your intended use for example other rights such as publicity privacy or moral rights may limit how you use the material learn more about cc licensing or use the license for your own material this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work make a donation this page is available in the following languages castellano castellano españa català dansk deutsch english esperanto français galego hrvatski indonesia italiano latviski lietuvių melayu nederlands norsk polski português português br română slovenščina suomeksi svenska türkçe íslenska česky ελληνικά беларуская русский українська العربية پارسی     한국어 this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work when you share everyone wins contribute today to creative commons     disclaimer this deed highlights only some of the key features and terms of the actual license it is not a license and has no legal value you should carefully review all of the terms and conditions of the actual license before using the licensed material creative commons is not a law firm and does not provide legal services distributing displaying or linking to this deed or the license that it summarizes does not create a lawyerclient or any other relationship what does attribute this work mean the page you came from contained embedded licensing metadata including how the creator wishes to be attributed for reuse you can use the html here to cite the work doing so will also include metadata on your page so that others can find the original work as well the applicable mediation rules will be designated in the copyright notice published with the work or if none then in the request for mediation unless otherwise designated in a copyright notice attached to the work the uncitral arbitration rules apply to any arbitration more info if supplied you must provide the name of the creator and attribution parties a copyright notice a license notice a disclaimer notice and a link to the material cc licenses prior to version  also require you to provide the title of the material if supplied and may have other slight differences more info in  you must indicate if you modified the material and retain an indication of previous modifications in  and earlier license versions the indication of changes is only required if you create a derivative marking guide more info you may also use a license listed as compatible at httpscreativecommonsorgcompatiblelicenses more info a commercial use is one primarily intended for commercial advantage or monetary compensation more info merely changing the format never creates a derivative more info the license prohibits application of effective technological measures defined with reference to article  of the wipo copyright treaty more info the rights of users under exceptions and limitations such as fair use and fair dealing are not affected by the cc licenses more info you may need to get additional permissions before using the material as you intend more info biolinerx  a drug development company careers  contact us home about us pipeline partnering news  events investors about biolinerx biolinerx is a clinicalstage biopharmaceutical company focused on oncology and immunology the company inlicenses novel compounds develops them through preclinical andor clinical stages and then partners with pharmaceutical companies for advanced clinical development andor commercialization company presentation learn more about biolinerx’s unique business model our history and achievements our clinical programs and next in line” advanced preclinical programs click here to open the biolinerx company presentation june  copyright �  biolinerx all rights reserved  terms of use  privacy policy web design by xg media    web development  imoon biolinerx  wikipedia biolinerx from wikipedia the free encyclopedia jump to navigation search biolinerx ltd type public traded as nasdaq blrx tase blrx industry biotechnology founded   headquarters modiin israel key people philip serlin ceo services drug development owners novartis   website wwwbiolinerxcom footnotes  references  biolinerx office in har hotzvim technology park jerusalem biolinerx hebrew ביוליין אר אקס‎‎ or bioline is a publicly traded drug development company that seeks to discover compounds for disease treatment and develop them into commercializable drugs headquartered in israel its shares are traded on the nasdaq capital market and on the tel aviv stock exchange contents  operations  pipeline  business model  corporate history  management  see also  references  external links operationsedit biolinerx is a drug development company that seeks to discover compounds with potential to treat a variety of diseases including cancer schizophrenia and cardiac deterioration when promising compounds are discovered bioline leads them through preclinical trials and engages other companies to advance the compounds development into commercializable drugs the company entered into its first major commercialization agreement in  when it partnered with ikaria holdings inc to develop its bl compound in  bioline entered into a commercialization agreement with cypress bioscience inc for development of its bl compound the agreement with cypress was canceled in  when the company was taken over by ramius llc pipelineedit below is a partial list of drug compounds in various stages of development by biolinerx unless indicated otherwise they have not obtained regulatory approval in relation to the diseases cited bl – orally available neuropathic pain bl – orally available gabaenhanced antipsychotic for treatment of schizophrenia bl – orally available small molecule for treatment of neuropathic pain bl – liquid polymer injected into patients suffering from acute myocardial infarction invented by smadar cohen of bengurion university bl  a potent and selective cannabinoid receptor type  cbr agonist intended as a novel treatment for dry eye syndrome des  bl – cream treatment for seborrheic keratosis skin lesions bl – orally available antiinflammatory drug invented by hermona soreq of the hebrew university of jerusalem bl – orally administered treatment for hepatitis c developed by professor philippe halfon cofounder and president of genoscience bl – secondgeneration ns protease inhibitor for oral treatment of hepatitis c invented by philippe halfon business modeledit see also bench to bedside and proof of concept biolines business model consists of three stages in the first stage called the bench stage the potential drug candidate is evaluated from both scientific and marketing perspectives in the second stage called the bedside stage bioline accompanies the drug through early clinical trials in the third stage the partner stage bioline enters into strategic partnership with a pharmaceutical company to see the drug through its advanced clinical trials and bring it to the market corporate historyedit biolinerx was established in  as a joint venture of teva hadasit bioholdings the jerusalem development authority yehuda zisapel and other investors it executed an initial public offering on the tel aviv stock exchange in february  raising  million nis  million – the tases largest biotech ipo until that time in august  biolines adrs began trading on the nasdaq capital market in january  biolinerx announced a deal with genoscience a french pharmaceutical company to jointly develop and market the bl compound as a treatment for hepatitis c at the end of  novartis acquired a  stake in the company as a strategic move to gain access to israelisourced drug candidates managementedit morris laster downstate medical center md and suny albany bsc alumnus was ceo of biolinerx until  he was replaced by kinneret savitsky alumnus of tel aviv university masters and phd and the hebrew university of jerusalem bsc early in  savitsky was replaced as ceo by bioline coo philip serlin on october   see alsoedit translational medicine ta bluetech index list of israeli companies quoted on the nasdaq referencesedit  blrx profile biolinerx ltd stock yahoo finance  retrieved  november    a b novartis makes m investment in biolinerx industry watch genetic engineering  biotechnology news    december  p    brinn david  june  biolinerx—israels biotech supermarket israelc archived from the original on  april  retrieved  november    habibvaldhorn shiri  april  biolinerx earns m milestone payment globes retrieved  november  permanent dead link  weinreb gali  may  biolinerx and cypress cancel schizophrenia drug agreement globes archived from the original on  june  retrieved  november    biolinerx inlicenses novel compound for treatment of neuropathic pain archived from the original on    israeli co to hold clinical trial for treatment of schizophrenia in india the hindu business line jerusalem  november  retrieved  november    biolinerx  september  biolinerx announces positive preliminary results from phase i clinical trial of bl for neuropathic pain press release jerusalem retrieved  november  – via business wire   bioline looks to heart attack treatment clinical trial globes  february  retrieved  november  permanent dead link  us company buys exclusive license for israeli heart attack drug for  million israelc  july  retrieved  november    httpwwwbiolinerxcomdefaultasppageiditemid  wrobel sharon  september  bioline rx gets european device confirmation for bl drug bloomberg retrieved  november    biolinerx has acquired the rights to compound bl from yissum and prof soreq the hebrew university of jerusalem the edmond and lily safra center for brain sciences  june  retrieved  november    biolinerx signs pact with genoscience  rfs pharma to develop and commercialize bl to treat hepatitis c pharmabizcom jerusalem israel  february  archived from the original on  february  retrieved  february    biolinerx—overview biolinerx  archived from the original on  september  retrieved  november  selfpublished source  grayeff yigal  january  biolinerx signs  deals to develop drugs jerusalem post archived from the original on  february  retrieved  november  – via ivc research center   cohen omri  february  biotech comes of age bioline floats at halfbillion shekel market cap themarker retrieved  november  bioline therapeutics today pulled off its initial public offering in tel aviv raising nis  million at a company valuation of nis  million making this the biggest flotation by a biotechnology company in local history   rheinheimer laura  february  biolinerx raises m in tases largest biomedical ipo jerusalem post retrieved  november  biolinerx ltd on wednesday priced the largest ever initial public offering of a biomedical company on the tel aviv stock exchange raising a total of nis  million or m   biolinerx adrs begin trading on nasdaq  august  retrieved  november  – via highbeam research citation not found  cohen tova  july  magnowski daniel ed biolinerx adrs to begin trading on nasdaq monday reuters   wang lu  january  achillion biolinerx jj snack rubicon us equity movers bloomberg news archived from the original on  january    kinneret livnat savitsky phd executive profile  biography bloomberg business retrieved  february    httpswwwbloombergcomresearchstockspeoplepersonasppersonidprivcapid external linksedit biojerusalem jerusalem development authority office of the chief scientist of israel v t e israeli companies traded on nasdaq healthcare alcobra biolinerx biondvax pharmaceutical compugen enzymotec given imaging kamada mazor robotics medigus oramed pharmaceuticals perrigo company pluristem therapeutics rewalk robotics rosetta genomics syneron medical communication  networks allot communications alvarion audiocodes b communications ceragon networks dsp group ezchip semiconductor gilat satellite networks internet gold golden lines orckit communications partner communications company radcom radvision rit technologies rr media software attunity bluephoenix solutions bos better online solutions check point software technologies clicksoftware technologies commtouch software cimatron cyberark formula systems  jacada magic software enterprises mind cti nice systems perion network radware sapiens international corporation nv verint systems wix electronics camtek ceva eltek kornit digital mellanox technologies nova measuring instruments orbotech solaredge tower semiconductor security  defense arotech elbit systems ituran location and control magal security systems pointer telocation rada electronic industries tat technologies consumer goods caesarstone sdotyam sodastream international conglomerates ampalamerican israel corporation elbit imaging isramco this company is americanbased but is traded on the tase as a result of a merger with israeli drug maker agis retrieved from httpsenwikipediaorgwindexphptitlebiolinerxoldid categories companies listed on tasebiotechnology companies established in biotechnology companies of israelbiotechnology companiescompanies listed on nasdaqdrug discovery companies establishments in israelhidden categories all articles with dead external linksarticles with dead external links from july articles with permanently dead external linksaccuracy disputes from february all articles with broken links to citationspages using deprecated image syntaxarticles containing hebrewlanguage text navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages עברית edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view biolinerx limited biolinerxltd  twitter skip to content home home home current page moments moments moments current page search query search twitter searches you follow follow following unfollow saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  language english bahasa indonesia bahasa melayu català čeština dansk deutsch english uk español filipino français hrvatski italiano magyar nederlands norsk polski português română slovenčina suomi svenska tiếng việt türkçe ελληνικά български език русский српски українська мова עִבְרִית العربية فارسی मराठी हिन्दी বাংলা ગુજરાતી தமிழ் ಕನ್ನಡ ภาษาไทย 한국어  简体 繁體 have an account log in have an account remember me · forgot password new to twitter sign up biolinerx limited biolinerxltd tweets tweets current page  following following  followers followers    more unmute biolinerxltd mute biolinerxltd follow following unfollow blocked unblock pending cancel biolinerx limited biolinerxltd israel biolinerxcom joined november   photos and videos photos and videos tweets tweets tweets current page tweets  replies media you blocked biolinerxltd are you sure you want to view these tweets viewing tweets wont unblock biolinerxltd yes view profile close biolinerx limited followed biolinerx limited‏ biolinerxltd h hours ago more copy link to tweet embed tweet httpwwwbiolinerxcomdefaultasppageiditemid … biolinerx announces additional investment from bvf partners lp blrx  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd jul  more copy link to tweet embed tweet httpwwwnationmultimediacomdetailstartupandit … tel aviv  china’s appetite for hightech investment  israel’s emergence as global innovation hub make ideal match  replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd jul  more copy link to tweet embed tweet httpswwwchinamoneynetworkcomcbridgeclosesitssecondhealthcarefundatm … blrx chinajv partners pe backer raises m for second healthcare fund  replies  retweet  likes reply retweet  retweeted  like liked thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd may  more copy link to tweet embed tweet httpwwwbioworldcomcontentbiolinerxmobilizedfdaphaseiiiblchallengesanofismozobilnearing … biolinerx mobilized by fda phase iii bl challenge to sanofis mozobil nearing blrx  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd mar  more copy link to tweet embed tweet biolinerx’s agi to be presented at aacr  httpwwwbiolinerxcomdefaultasppageiditemid … blrx  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd mar  more copy link to tweet embed tweet httpwwwglobescoilenarticlebiolinerxbuysukco … biolinerx buys uk co agalimmune blrx  replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd mar  more copy link to tweet embed tweet httpwwwbiolinerxcomdefaultasppageiditemid … biolinerx reports year end  financial results blrx  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd mar  more copy link to tweet embed tweet httpwwwbiolinerxcomdefaultasppageiditemid … biolinerx announces acquisition of agalimmune ltd to accelerate expansion of immunooncology pipeline blrx  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd mar  more copy link to tweet embed tweet blrx’s agi harnesses natural antibodies to induce antitumor response transforming cold to hot tumors expanding treatment potentialpictwittercomujdpxqhb  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd mar  more copy link to tweet embed tweet httpwwwajmccomjournalsevidencebasedoncologyfebruaryhelpingcancerpatientsandcaregiversnavigateimmunotherapytreatment … immunotherapy is one of the fastest growing areas of cancer research ajmcjournal  replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd mar  more copy link to tweet embed tweet bl moa in aml and in combination with flt bcl inh published in leukemia leading scientific journal httpswwwncbinlmnihgovpubmed   replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd jan  more copy link to tweet embed tweet httpbufflyjkaawi  biolinerx announces initiation of immunooncology phase  study bl and keytruda® for pancreatic cancer blrx  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd  dec  more copy link to tweet embed tweet httpbufflyidjbx   if we get it figured out for leukemia we can figure it out for other cancers too”  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd  dec  more copy link to tweet embed tweet httpbufflygsmul  cancer gene predicts treatment response leukemia  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd  dec  more copy link to tweet embed tweet httpbufflyhjmpp  immunotherapy holds promise for aml  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd  dec  more copy link to tweet embed tweet httpbufflygulnwy  biolinerx presents positive phase a aml study and mechanismofaction data for bl oncology platform at ash  replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd  nov  more copy link to tweet embed tweet httpbufflyggmc  this revolutionary treatment kills cancer from the inside out clevelandclinic  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd  nov  more copy link to tweet embed tweet httpbufflyfofk  leukemia forumation in cells driven by bone dna mutation scienmag  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd  nov  more copy link to tweet embed tweet httpbufflyfotzy  starving cancer cells leads to significant improvement in mice with cancer cells harvardscience cancer science  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo biolinerx limited‏ biolinerxltd  nov  more copy link to tweet embed tweet httpbufflyghdadg  a common virus may lead to blood cancer science upi  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo biolinerxltd hasnt tweeted yet back to top ↑ loading seems to be taking a while twitter may be over capacity or experiencing a momentary hiccup try again or visit twitter status for more information new to twitter sign up now to get your own personalized timeline sign up you may also like · refresh false   twitter about help center terms privacy policy cookies ads info close choose a trend location dismiss close previous next close go to a persons profile searches you follow follow following unfollow saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  close promote this tweet close block cancel block add a location to your tweets when you tweet with a location twitter stores that location you can switch location onoff before each tweet and always have the option to delete your location history learn more turn location on not now close share location results from send close your lists close create a new list list name description under  characters optional privacy public · anyone can follow this list private · only you can access this list save list close close copy link to tweet heres the url for this tweet copy it to easily share with friends close embed this tweet embed this video add this tweet to your website by copying the code below learn more add this video to your website by copying the code below learn more hmm there was a problem reaching the server try again include parent tweet include media by embedding twitter content in your website or app you are agreeing to the twitter developer agreement and developer policy preview close why youre seeing this ad close log in to twitter remember me · forgot password dont have an account sign up » close sign up for twitter not on twitter sign up tune into the things you care about and get updates as they happen sign up have an account log in » close twoway sending and receiving short codes country code for customers of united states  any canada  any united kingdom  vodafone orange  o brazil  nextel tim haiti  digicel voila ireland  vodafone o india  bharti airtel videocon reliance indonesia  axis  telkomsel indosat xl axiata italy  wind  vodafone » see sms short codes for other countries close confirmation close   close skip all welcome home this timeline is where you’ll spend most of your time getting instant updates about what matters to you tweets not working for you hover over the profile pic and click the following button to unfollow any account say a lot with a little when you see a tweet you love tap the heart — it lets the person who wrote it know you shared the love spread the word the fastest way to share someone else’s tweet with your followers is with a retweet tap the icon to send it instantly join the conversation add your thoughts about any tweet with a reply find a topic you’re passionate about and jump right in learn the latest get instant insight into what people are talking about now get more of what you love follow more accounts to get instant updates about topics you care about find whats happening see the latest conversations about any topic instantly never miss a moment catch up instantly on the best stories happening as they unfold back next next tweet from user biolinerx  wikipedia biolinerx from wikipedia the free encyclopedia jump to navigation search biolinerx ltd type public traded as nasdaq blrx tase blrx industry biotechnology founded   headquarters modiin israel key people philip serlin ceo services drug development owners novartis   website wwwbiolinerxcom footnotes  references  biolinerx office in har hotzvim technology park jerusalem biolinerx hebrew ביוליין אר אקס‎‎ or bioline is a publicly traded drug development company that seeks to discover compounds for disease treatment and develop them into commercializable drugs headquartered in israel its shares are traded on the nasdaq capital market and on the tel aviv stock exchange contents  operations  pipeline  business model  corporate history  management  see also  references  external links operationsedit biolinerx is a drug development company that seeks to discover compounds with potential to treat a variety of diseases including cancer schizophrenia and cardiac deterioration when promising compounds are discovered bioline leads them through preclinical trials and engages other companies to advance the compounds development into commercializable drugs the company entered into its first major commercialization agreement in  when it partnered with ikaria holdings inc to develop its bl compound in  bioline entered into a commercialization agreement with cypress bioscience inc for development of its bl compound the agreement with cypress was canceled in  when the company was taken over by ramius llc pipelineedit below is a partial list of drug compounds in various stages of development by biolinerx unless indicated otherwise they have not obtained regulatory approval in relation to the diseases cited bl – orally available neuropathic pain bl – orally available gabaenhanced antipsychotic for treatment of schizophrenia bl – orally available small molecule for treatment of neuropathic pain bl – liquid polymer injected into patients suffering from acute myocardial infarction invented by smadar cohen of bengurion university bl  a potent and selective cannabinoid receptor type  cbr agonist intended as a novel treatment for dry eye syndrome des  bl – cream treatment for seborrheic keratosis skin lesions bl – orally available antiinflammatory drug invented by hermona soreq of the hebrew university of jerusalem bl – orally administered treatment for hepatitis c developed by professor philippe halfon cofounder and president of genoscience bl – secondgeneration ns protease inhibitor for oral treatment of hepatitis c invented by philippe halfon business modeledit see also bench to bedside and proof of concept biolines business model consists of three stages in the first stage called the bench stage the potential drug candidate is evaluated from both scientific and marketing perspectives in the second stage called the bedside stage bioline accompanies the drug through early clinical trials in the third stage the partner stage bioline enters into strategic partnership with a pharmaceutical company to see the drug through its advanced clinical trials and bring it to the market corporate historyedit biolinerx was established in  as a joint venture of teva hadasit bioholdings the jerusalem development authority yehuda zisapel and other investors it executed an initial public offering on the tel aviv stock exchange in february  raising  million nis  million – the tases largest biotech ipo until that time in august  biolines adrs began trading on the nasdaq capital market in january  biolinerx announced a deal with genoscience a french pharmaceutical company to jointly develop and market the bl compound as a treatment for hepatitis c at the end of  novartis acquired a  stake in the company as a strategic move to gain access to israelisourced drug candidates managementedit morris laster downstate medical center md and suny albany bsc alumnus was ceo of biolinerx until  he was replaced by kinneret savitsky alumnus of tel aviv university masters and phd and the hebrew university of jerusalem bsc early in  savitsky was replaced as ceo by bioline coo philip serlin on october   see alsoedit translational medicine ta bluetech index list of israeli companies quoted on the nasdaq referencesedit  blrx profile biolinerx ltd stock yahoo finance  retrieved  november    a b novartis makes m investment in biolinerx industry watch genetic engineering  biotechnology news    december  p    brinn david  june  biolinerx—israels biotech supermarket israelc archived from the original on  april  retrieved  november    habibvaldhorn shiri  april  biolinerx earns m milestone payment globes retrieved  november  permanent dead link  weinreb gali  may  biolinerx and cypress cancel schizophrenia drug agreement globes archived from the original on  june  retrieved  november    biolinerx inlicenses novel compound for treatment of neuropathic pain archived from the original on    israeli co to hold clinical trial for treatment of schizophrenia in india the hindu business line jerusalem  november  retrieved  november    biolinerx  september  biolinerx announces positive preliminary results from phase i clinical trial of bl for neuropathic pain press release jerusalem retrieved  november  – via business wire   bioline looks to heart attack treatment clinical trial globes  february  retrieved  november  permanent dead link  us company buys exclusive license for israeli heart attack drug for  million israelc  july  retrieved  november    httpwwwbiolinerxcomdefaultasppageiditemid  wrobel sharon  september  bioline rx gets european device confirmation for bl drug bloomberg retrieved  november    biolinerx has acquired the rights to compound bl from yissum and prof soreq the hebrew university of jerusalem the edmond and lily safra center for brain sciences  june  retrieved  november    biolinerx signs pact with genoscience  rfs pharma to develop and commercialize bl to treat hepatitis c pharmabizcom jerusalem israel  february  archived from the original on  february  retrieved  february    biolinerx—overview biolinerx  archived from the original on  september  retrieved  november  selfpublished source  grayeff yigal  january  biolinerx signs  deals to develop drugs jerusalem post archived from the original on  february  retrieved  november  – via ivc research center   cohen omri  february  biotech comes of age bioline floats at halfbillion shekel market cap themarker retrieved  november  bioline therapeutics today pulled off its initial public offering in tel aviv raising nis  million at a company valuation of nis  million making this the biggest flotation by a biotechnology company in local history   rheinheimer laura  february  biolinerx raises m in tases largest biomedical ipo jerusalem post retrieved  november  biolinerx ltd on wednesday priced the largest ever initial public offering of a biomedical company on the tel aviv stock exchange raising a total of nis  million or m   biolinerx adrs begin trading on nasdaq  august  retrieved  november  – via highbeam research citation not found  cohen tova  july  magnowski daniel ed biolinerx adrs to begin trading on nasdaq monday reuters   wang lu  january  achillion biolinerx jj snack rubicon us equity movers bloomberg news archived from the original on  january    kinneret livnat savitsky phd executive profile  biography bloomberg business retrieved  february    httpswwwbloombergcomresearchstockspeoplepersonasppersonidprivcapid external linksedit biojerusalem jerusalem development authority office of the chief scientist of israel v t e israeli companies traded on nasdaq healthcare alcobra biolinerx biondvax pharmaceutical compugen enzymotec given imaging kamada mazor robotics medigus oramed pharmaceuticals perrigo company pluristem therapeutics rewalk robotics rosetta genomics syneron medical communication  networks allot communications alvarion audiocodes b communications ceragon networks dsp group ezchip semiconductor gilat satellite networks internet gold golden lines orckit communications partner communications company radcom radvision rit technologies rr media software attunity bluephoenix solutions bos better online solutions check point software technologies clicksoftware technologies commtouch software cimatron cyberark formula systems  jacada magic software enterprises mind cti nice systems perion network radware sapiens international corporation nv verint systems wix electronics camtek ceva eltek kornit digital mellanox technologies nova measuring instruments orbotech solaredge tower semiconductor security  defense arotech elbit systems ituran location and control magal security systems pointer telocation rada electronic industries tat technologies consumer goods caesarstone sdotyam sodastream international conglomerates ampalamerican israel corporation elbit imaging isramco this company is americanbased but is traded on the tase as a result of a merger with israeli drug maker agis retrieved from httpsenwikipediaorgwindexphptitlebiolinerxoldid categories companies listed on tasebiotechnology companies established in biotechnology companies of israelbiotechnology companiescompanies listed on nasdaqdrug discovery companies establishments in israelhidden categories all articles with dead external linksarticles with dead external links from july articles with permanently dead external linksaccuracy disputes from february all articles with broken links to citationspages using deprecated image syntaxarticles containing hebrewlanguage text navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages עברית edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view